Yoshiki Ishii

2.5k total citations
84 papers, 1.9k citations indexed

About

Yoshiki Ishii is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, Yoshiki Ishii has authored 84 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 19 papers in Physiology and 17 papers in Oncology. Recurrent topics in Yoshiki Ishii's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Asthma and respiratory diseases (14 papers) and Medical Imaging and Pathology Studies (10 papers). Yoshiki Ishii is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Asthma and respiratory diseases (14 papers) and Medical Imaging and Pathology Studies (10 papers). Yoshiki Ishii collaborates with scholars based in Japan, United States and Netherlands. Yoshiki Ishii's co-authors include Satoshi Kitamura, Takeshi Fukuda, Akihiro Takemasa, Kazuyuki Chibana, Sakae Fujimoto, Peter J. Del Vecchio, Asrar B. Malik, Hideaki Yamasawa, Hirokuni Hirata and Catherine A. Partridge and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Yoshiki Ishii

80 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiki Ishii Japan 22 879 478 433 398 354 84 1.9k
Makoto Dohi Japan 25 533 0.6× 551 1.2× 668 1.5× 271 0.7× 233 0.7× 63 2.1k
Bernt van den Blink Netherlands 27 1.1k 1.3× 809 1.7× 568 1.3× 558 1.4× 269 0.8× 50 2.5k
Martyn Foster United Kingdom 25 654 0.7× 468 1.0× 383 0.9× 488 1.2× 198 0.6× 39 1.9k
Etsuro Yamaguchi Japan 30 1.3k 1.5× 950 2.0× 475 1.1× 399 1.0× 274 0.8× 125 2.6k
Fumitaka Ogushi Japan 25 718 0.8× 283 0.6× 365 0.8× 547 1.4× 453 1.3× 116 2.1k
Erica Bazzan Italy 20 1.1k 1.2× 899 1.9× 493 1.1× 452 1.1× 218 0.6× 66 2.0k
Kazuhito Kawabata Japan 18 427 0.5× 205 0.4× 421 1.0× 453 1.1× 220 0.6× 54 1.6k
Li-zhen Song United States 11 727 0.8× 686 1.4× 476 1.1× 294 0.7× 151 0.4× 13 1.7k
William D. Hardie United States 29 1.5k 1.7× 337 0.7× 255 0.6× 544 1.4× 235 0.7× 68 2.3k
Nathaniel M. Weathington United States 25 527 0.6× 242 0.5× 512 1.2× 733 1.8× 335 0.9× 40 1.9k

Countries citing papers authored by Yoshiki Ishii

Since Specialization
Citations

This map shows the geographic impact of Yoshiki Ishii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiki Ishii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiki Ishii more than expected).

Fields of papers citing papers by Yoshiki Ishii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiki Ishii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiki Ishii. The network helps show where Yoshiki Ishii may publish in the future.

Co-authorship network of co-authors of Yoshiki Ishii

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiki Ishii. A scholar is included among the top collaborators of Yoshiki Ishii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiki Ishii. Yoshiki Ishii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakamura, Yusuke, Yasuo Shimizu, Yasuhiro Horibata, et al.. (2017). Changes of plasmalogen phospholipid levels during differentiation of induced pluripotent stem cells 409B2 to endothelial phenotype cells. Scientific Reports. 7(1). 9377–9377. 14 indexed citations
2.
3.
Maemondo, Makoto, Tatsuro Fukuhara, Shunichi Sugawara, et al.. (2016). NEJ026: Phase III study comparing bevacizumab plus erlotinib to erlotinib in patients with untreated NSCLC harboring activating EGFR mutations. Annals of Oncology. 27. vi447–vi447. 5 indexed citations
4.
5.
Watanabe, Satoshi, Yuji Minegishi, Hirohisa Yoshizawa, et al.. (2014). Effectiveness of Gefitinib against Non–Small-Cell Lung Cancer with the Uncommon EGFR Mutations G719X and L861Q. Journal of Thoracic Oncology. 9(2). 189–194. 163 indexed citations
6.
Shimizu, Yasuo, Atsushi Takise, Hisaki Morita, et al.. (2014). Serum glycopeptidolipid core IgA antibody levels in patients with chest computed tomography features of mycobacterium aviumintracellulare complex pulmonary disease.. PubMed. 28(3). 399–405. 2 indexed citations
7.
Takemasa, Akihiro, Yoshiki Ishii, & Takeshi Fukuda. (2012). A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice. European Respiratory Journal. 40(6). 1475–1482. 112 indexed citations
8.
9.
Kiwamoto, Takumi, Yoshiki Ishii, Yuko Morishima, et al.. (2010). Blockade of cysteinyl leukotriene-1 receptors suppresses airway remodelling in mice overexpressing GATA-3. Clinical & Experimental Allergy. 41(1). 116–128. 13 indexed citations
10.
Ishii, Yoshiki, Sakae Fujimoto, & Takeshi Fukuda. (2006). Gefitinib Prevents Bleomycin-induced Lung Fibrosis in Mice. American Journal of Respiratory and Critical Care Medicine. 174(5). 550–556. 91 indexed citations
11.
Tasaka, Sadatomo, Hidefumi Koh, Wakako Yamada, et al.. (2005). Attenuation of Endotoxin-Induced Acute Lung Injury by the Rho-Associated Kinase Inhibitor, Y-27632. American Journal of Respiratory Cell and Molecular Biology. 32(6). 504–510. 107 indexed citations
12.
Chibana, Kazuyuki, et al.. (2003). Up-Regulation of Cysteinyl Leukotriene 1 Receptor by IL-13 Enables Human Lung Fibroblasts to Respond to Leukotriene C4 and Produce Eotaxin. The Journal of Immunology. 170(8). 4290–4295. 69 indexed citations
13.
Cheng, Gang, Masafumi Arima, Kyoko Honda, et al.. (2002). Anti–Interleukin-9 Antibody Treatment Inhibits Airway Inflammation and Hyperreactivity in Mouse Asthma Model. American Journal of Respiratory and Critical Care Medicine. 166(3). 409–416. 146 indexed citations
14.
Ishii, Yoshiki, et al.. (2000). Aerosolized Administration of N -Acetylcysteine Attenuates Lung Fibrosis Induced by Bleomycin in Mice. American Journal of Respiratory and Critical Care Medicine. 162(1). 225–231. 185 indexed citations
15.
Yamasawa, Hideaki, Yoshiki Ishii, & Satoshi Kitamura. (1996). A Clinical Study on Liver Metastases in Patients with Primary Lung Cancer.. Haigan. 36(1). 33–40. 3 indexed citations
16.
Ishii, Yoshiki, et al.. (1996). [Utility of thoracoscopy for diagnosis of pulmonary diseases in clinical pulmonary medicine].. PubMed. 34 Suppl. 159–65.
17.
Ishii, Yoshiki, et al.. (1995). A Case of Malignant Mesothelioma with Abnormal CDKN2 Gene Accompanied by Malignant Melanoma.. Haigan. 35(7). 923–929. 1 indexed citations
18.
Ishii, Yoshiki, I. Morita, S. Murota, & Satoshi Kitamura. (1993). Hyperoxia decreases cyclooxygenase activity in endothelial cells. Prostaglandins Leukotrienes and Essential Fatty Acids. 48(6). 455–461. 8 indexed citations
19.
Ishii, Yoshiki, Catherine A. Partridge, Peter J. Del Vecchio, & Asrar B. Malik. (1992). Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2.. Journal of Clinical Investigation. 89(3). 794–802. 93 indexed citations
20.
Matsumoto, Shuzo, et al.. (1990). [A case of complete remission in brain metastasis from lung adenocarcinoma with EAP (etoposide, adriamycin, cisplatin)].. PubMed. 17(9). 1933–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Makoto Dohi Breakdown of academic impact, for papers by Bernt van den Blink Breakdown of academic impact, for papers by Martyn Foster Breakdown of academic impact, for papers by Etsuro Yamaguchi Breakdown of academic impact, for papers by Fumitaka Ogushi Breakdown of academic impact, for papers by Erica Bazzan Breakdown of academic impact, for papers by Kazuhito Kawabata Breakdown of academic impact, for papers by Li-zhen Song Breakdown of academic impact, for papers by William D. Hardie Breakdown of academic impact, for papers by Nathaniel M. Weathington
Rankless by CCL
2026